Genomics & Informatics

Korea Genome Organization (한국유전체학회)
권호 표지
DOI QR코드

DOI QR Code

In Vivo Target RNA Specificity of Trans-Splicing Phenomena by the Group I Intron

  • Song, Min-Sun (Department of Molecular Biology, Institute of Nanosensor and Biotechnology, Dankook University) ;
  • Lee, Seong-Wook (Department of Molecular Biology, Institute of Nanosensor and Biotechnology, Dankook University)
  • Published : 2008.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The Tetrahymena group I intron has been shown to employ a trans-splicing reaction and has been modified to specifically target and replace human telomerase reverse transcriptase (hTERT) RNA with a suicide gene transcript, resulting in the induction of selective cytotoxicity in cancer cells that express the target RNA, in animal models as well as in cell cultures. In this study, we evaluated the target RNA specificity of trans-splicing phenomena by the group I intron in mice that were intraperitoneally inoculated with hTERT-expressing human cancer cells to validate the anti-cancer therapeutic applicability of the group I intron. To this end, an adenoviral vector that encoded for the hTERT-targeting group I intron was constructed and systemically injected into the animal. 5'-end RACE-PCR and sequencing analyses of the trans-spliced cDNA clones revealed that all of the analyzed products in the tumor tissue of the virus-infected mice resulted from reactions that were generated only with the targeted hTERT RNA. This study implies the in vivo target specificity of the trans-splicing group I intron and hence suggests that RNA replacement via a trans-splicing reaction by the group I intron is a potent anti-cancer genetic approach.

Keywords

References

  1. Drude, I., Dombos, V., Vauleon, S., and Muller, S. (2007). Drugs made of RNA: development and application of engineered RNAs for gene therapy. Mini Rev. Med. Chem. 7, 912-931. https://doi.org/10.2174/138955707781662609
  2. Hong, S.H., Jeong, J.S., Lee, Y.J., Jung, H.I., Cho, K.S., Kim, C.M., Kwon, B.S., Sullenger, B.A., Lee, S.W., and Kim, I.H. (2008). In Vivo reprogramming of hTERT by trans -splicing ribozyme to target tumor cells. Mol. Ther. 16, 74-80. https://doi.org/10.1038/sj.mt.6300282
  3. Jeong, J.S., Lee, S.W., Hong, S.H., Lee, Y.J., Jung, H.I., Cho, K.S., Seo, H.H., Lee, S.J., Park, S., Song, M.S., Kim, C.M., and Kim, I.H. (2008). Antitumor effects of systemically delivered adenovirus harboring trans -splicing ribozyme in intrahepatic colon cancer mouse model. Clin. Cancer Res. 14, 281-290. https://doi.org/10.1158/1078-0432.CCR-07-1524
  4. Kastanos, E., Hjiantoniou, E., and Phylactou, L.A. (2004). Restoration of protein synthesis in pancreatic cancer cells by trans -splicing ribozymes. Biochem. Biophys. Res. Commun. 322, 930-934. https://doi.org/10.1016/j.bbrc.2004.07.203
  5. Kwon, B.S., Jung, H.S., Song, M.S., Cho, K.S., Kim, S.C., Kimm, K., Jeong, J.S., Kim, I.H., and Lee, S.W. (2005). Specific regression of human cancer cells by ribozymemediated targeted replacement of tumor-specific transcript. Mol. Ther. 12, 824-834. https://doi.org/10.1016/j.ymthe.2005.06.096
  6. Lan, N., Howrey, R.P., Lee, S.W., Smith, C.A., and Sullenger, B.A. (1998). Ribozyme-mediated repair of sickle ${\beta}-globin$ mRNAs in erythrocyte precursors. Science 280, 1593-1596. https://doi.org/10.1126/science.280.5369.1593
  7. Phylactou, L.A., Darrah, C., and Wood, M.A.J. (1998). Ribozyme-mediated trans -splicing of a trinucleotide repeat. Nat. Genet. 18, 378-381. https://doi.org/10.1038/ng0498-378
  8. Rogers, C.S., Vanoye, C.G., Sullenger, B.A., and George, A.L. (2002). Functional repair of a mutant chloride channel using a trans -splicing ribozyme. J. Clin. Invest. 110, 1783-1798. https://doi.org/10.1172/JCI200216481
  9. Ryu, K.J., Kim, J.H., and Lee, S.W. (2003). Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing. Mol. Ther. 7, 386-395. https://doi.org/10.1016/S1525-0016(02)00063-1
  10. Shin, K.S., Sullenger, B.A., and Lee, S.W. (2004). Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA. Mol. Ther. 10, 365-372. https://doi.org/10.1016/j.ymthe.2004.05.007
  11. Song, M.S., and Lee, S.W. (2006). Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme. FEBS. Lett. 580, 5033-5043. https://doi.org/10.1016/j.febslet.2006.08.021

Cited by

  1. RNA Mapping of Mutant Myotonic Dystrophy Protein Kinase 3'-Untranslated Region Transcripts vol.7, pp.4, 2009, https://doi.org/10.5808/GI.2009.7.4.181